Evidence map›Paper›PMID 34192059›Full record

ArticleJournal of clinical and translational science2021

Informed consent: Old and new challenges in the context of the COVID-19 pandemic.

Erin Rothwell, Donna Brassil, Marietta Barton-Baxter, Kimberly A Brownley, Neal W Dickert, Daniel E Ford, Stephanie A Kraft, Jennifer B McCormick, Benjamin S Wilfond

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Conducting clinical research in the era of the COVID-19 pandemic: Challenges and lessons for Speech-Language Pathology and Audiology research.The South African journal of communication disorders = Die Suid-Afrikaanse tydskrif vir Kommunikasieafwykings · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Managing the risks and benefits of clinical research in response to a pandemic.Journal of clinical and translational science · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Erin RothwellDepartment of Ob/Gyn, School of Medicine, University of Utah, Salt Lake City, UT, USA.ORCID https://orcid.org/0000-0002-2294-2299
Donna BrassilRockefeller University, New York, NY, USA.
Marietta Barton-BaxterUniversity of Kentucky Center for Clinical and Translational Science, Lexington, KY, USA.
Kimberly A BrownleyDepartment of Psychiatry, School of Medicine, NC Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID https://orcid.org/0000-0002-1381-1852
Neal W DickertEmory University School of Medicine, Department of Medicine, and Georgia Clinical and Translational Science Alliancet, Atlanta, GA, USA.
Daniel E FordJohns Hopkins Institute for Clinical and Translational Research, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-2549-2289
Stephanie A KraftTreuman Katz Center for Pediatric Bioethics, Seattle Children's Research Institute and Division of Bioethics and Palliative Care, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.
Jennifer B McCormickDepartment of Humanities, College of Medicine, Pennsylvania State University, and Penn State Clinical and Translational Science Institute, Hershey, PA, USA.
Benjamin S WilfondTreuman Katz Center for Pediatric Bioethics, Seattle Children's Hospital and Research Institute; Department of Pediatrics, University of Washington School of Medicine; Institute of Translational Health Sciences, Seattle, WA, USA.

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
QAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7M
Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational SuccessUL1TR001866 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY, KRUEGER, JAMES G · 2016 to 2025
$40.6M
Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Penn State Clinical and Translational Science InstituteUL1TR002014 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI KRASCHNEWSKI, JENNIFER L. · 2016 to 2025
$33.7M
University of Utah Center for Clinical and Translational ScienceUL1TR001067 · NCATS · UNIVERSITY OF UTAH · PI DERE, WILLARD H., HESS, RACHEL · 2013 to 2017
$19.8M
CTSA Coordinating Center for Leading Innovation and Collaboration (CLIC)U24TR002260 · NCATS · UNIVERSITY OF ROCHESTER · PI OSSIP, DEBORAH J, ZAND, MARTIN S · 2017 to 2021
$19.0M
NCATS NIH HHS U24 TR002260NCATS NIH HHS UL1 TR001067NCATS NIH HHS UL1 TR001866NCATS NIH HHS UL1 TR001998NCATS NIH HHS UL1 TR002014NCATS NIH HHS UL1 TR002319NCATS NIH HHS UL1 TR002378NCATS NIH HHS UL1 TR002489NCATS NIH HHS UL1 TR003098
6 · The paper itself

Abstract

In this paper, we address how the COVID-19 pandemic has impacted informed consent for clinical research through examining experiences within Clinical and Translation Science Award (CTSA) institutions. We begin with a brief overview of informed consent and the challenges that existed prior to COVID-19. Then, we discuss how informed consent processes were modified or changed to address the pandemic, consider what lessons were learned, and present research and policy steps to prepare for future research and public health crises. The experiences and challenges for CTSA institutions offer an important perspective for examining what we have learned about informed consent and determining the next steps for improving the consent process.

Indexed as

clinical researchCOVID-19CTSAInformed consentpandemic

Identifiers

PMID34192059
PMCPMC8193198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.